53:
was the first to develop a bacterial mRNA vaccine, which could provide a fast response against an aggressive bacterial infection and antibiotic resistant strains. Furthermore, the team is developing novel therapeutic strategies to treat different types of cancers using novel drug targets that they identify, cancer vaccines or by using bacterial toxins in the form of mRNA to kill tumor cells.
17:
52:
in an animal. Through this approach they have induced therapeutic gene expression of desired proteins (including novel approaches for cell specific, high efficiency therapeutic genome editing), which has implications in cancer, rare genetic diseases and infectious diseases. Recently, the Peer lab
34:
Peer is a scientific advisory board member in more than 15 companies and on the scientific advisory board of 20 journals. He is a past
President of the Israeli Chapter of the Controlled Release Society. In 2014 he was elected to the Israel Young Academy of Science. In 2023 he was elected to the US
56:
On top of this, the Peer lab generated a very large lipid library with unique features. Some of these lipids have been licensed to several major pharmaceutical companies and are now under clinical development as carriers for siRNA, mRNA, and circRNA for different indications including cancer,
43:
Prof. Peer pioneered the field of active cellular targeting of RNA payloads into specific cell types. His lab was among the first to demonstrate immunomodulation through a systemic delivery of RNA-loaded targeted nanocarriers. The team also pioneered the use of
31:(TAU). He is also the Vice President for Research and Development at TAU. In 2017 he co-founded and acts as the managing director of SPARK Tel Aviv, Center for Translational Medicine. From 2016–2020 he was the chair of the TAU Cancer Biology Research Center.
277:
48:
to reprogram immune cells and discover new therapeutic modalities. In addition, his lab was the first to show systemic, cell specific delivery of
381:
221:
240:
101:
2017 Nanos Award - World Leader Award for influential contributions to the field of NanoMedicine, CLINAM, Basel, Switzerland.
259:
185:
203:
84:
77:
70:
376:
295:
149:
331:
8:
352:
95:
2014 Elected
President, Israeli Chapter of the Controlled Release Society (2 years term).
28:
204:"New platform based on biology and nanotechnology carries mRNA directly to target cells"
167:
131:
313:
89:
2014 Innovator Award, cancer therapeutics (The inaugural Untold News Award, 2014).
296:"Researchers divided on future of cannabis as a whole plant or isolated medicine"
278:"Dan Peer: "Mi trabajo es ciencia ficción: trato de hacer realidad ideas locas ""
110:
2022 Elected
President, Israeli Society of Extracellular Vesicles (one year term)
361:
356:
27:
is a
Professor and the Director of the Laboratory of Precision NanoMedicine at
370:
104:
2020 Litwin IBD Pioneers Award, Crohn's and
Colitis Foundation of America.
69:
2008 Alon fellowship for outstanding young researchers, awarded by the
113:
2023 Elected
International Member, US National Academy of Engineering.
107:
2021 Distinguished
Research Award for Genome Editing, Genescript.
241:"Nano-bullet tech shoots down brain cancer in Tel Aviv U study"
57:
infectious diseases, rare genetic diseases and inflammation.
76:
49:
45:
16:
260:"Cannabis to treat cancer? Israeli scientist thinks so"
98:
314:"The Kenneth Rainin Foundation 2010 Innovator Awards"
168:"TAU professor appointed to Young Academy of Science"
132:"Dan Peer Lab, Tel Aviv University - Prof. Dan Peer"
222:"TAU sets up translational medical research center"
368:
92:2014 Elected Member, Israel Young Academy.
15:
186:"Beyin kanseri tedavisinde büyük buluş"
369:
257:
382:Academic staff of Tel Aviv University
13:
238:
14:
393:
346:
83:2013 Breakthrough Award from the
35:National Academy of Engineering.
154:Controlled Release Society (CRS)
38:
324:
306:
288:
258:Arnold, Janice (5 March 2019).
270:
251:
232:
214:
196:
178:
160:
142:
124:
1:
284:(in Spanish). 19 August 2019.
228:(in Hebrew). 30 January 2018.
117:
71:Israeli Ministry of Education
7:
10:
398:
336:Kenneth Rainin Foundation
318:Kenneth Rainin Foundation
85:Kenneth Rainin Foundation
78:Kenneth Rainin Foundation
60:
355:publications indexed by
264:The Canadian Jewish News
21:
19:
20:Portrait of Dan Peer
362:Patents by Dan Peer
245:The Times of Israel
172:Tel Aviv University
136:Tel Aviv University
29:Tel Aviv University
22:
332:"Recipients 2013"
389:
340:
339:
328:
322:
321:
310:
304:
303:
292:
286:
285:
274:
268:
267:
255:
249:
248:
236:
230:
229:
218:
212:
211:
200:
194:
193:
182:
176:
175:
164:
158:
157:
146:
140:
139:
128:
397:
396:
392:
391:
390:
388:
387:
386:
367:
366:
349:
344:
343:
330:
329:
325:
312:
311:
307:
294:
293:
289:
276:
275:
271:
256:
252:
239:Shamah, David.
237:
233:
220:
219:
215:
202:
201:
197:
184:
183:
179:
166:
165:
161:
148:
147:
143:
130:
129:
125:
120:
63:
41:
12:
11:
5:
395:
385:
384:
379:
365:
364:
359:
357:Google Scholar
348:
347:External links
345:
342:
341:
323:
305:
287:
269:
250:
231:
213:
195:
177:
174:. 14 May 2014.
159:
141:
122:
121:
119:
116:
115:
114:
111:
108:
105:
102:
99:
96:
93:
90:
87:
81:
74:
65:Partial list:
62:
59:
40:
37:
9:
6:
4:
3:
2:
394:
383:
380:
378:
377:Living people
375:
374:
372:
363:
360:
358:
354:
351:
350:
337:
333:
327:
319:
315:
309:
301:
297:
291:
283:
279:
273:
265:
261:
254:
246:
242:
235:
227:
223:
217:
209:
205:
199:
192:(in Turkish).
191:
187:
181:
173:
169:
163:
155:
151:
145:
137:
133:
127:
123:
112:
109:
106:
103:
100:
97:
94:
91:
88:
86:
82:
79:
75:
72:
68:
67:
66:
58:
54:
51:
47:
39:Research work
36:
32:
30:
26:
18:
335:
326:
317:
308:
299:
290:
281:
272:
263:
253:
244:
234:
225:
216:
207:
198:
189:
180:
171:
162:
153:
144:
135:
126:
64:
55:
42:
33:
24:
23:
371:Categories
300:Daily Hive
150:"Dan Peer"
118:References
282:La Nación
80:(CA, USA)
353:Dan Peer
208:Phys.org
25:Dan Peer
226:Globes
61:Awards
190:Şalom
50:mRNA
46:RNAi
373::
334:.
316:.
298:.
280:.
262:.
243:.
224:.
206:.
188:.
170:.
152:.
134:.
338:.
320:.
302:.
266:.
247:.
210:.
156:.
138:.
73:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
